Log in to save to my catalogue

Medication-related osteonecrosis of the jaw: Clinical and practical guidelines

Medication-related osteonecrosis of the jaw: Clinical and practical guidelines

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4820581

Medication-related osteonecrosis of the jaw: Clinical and practical guidelines

About this item

Full title

Medication-related osteonecrosis of the jaw: Clinical and practical guidelines

Publisher

Mumbai: Medknow Publications & Media Pvt. Ltd

Journal title

Journal of International Society of Preventive and Community Dentistry, 2016-03, Vol.6 (2), p.97-104

Language

English

Formats

Publication information

Publisher

Mumbai: Medknow Publications & Media Pvt. Ltd

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Medication-related osteonecrosis of the jaw (MRONJ) is a severe adverse drug reaction, consisting of progressive bone destruction in the maxillofacial region of patients. ONJ can be caused by two pharmacological agents: Antiresorptive (including bisphosphonates (BPs) and receptor activator of nuclear factor kappa-B ligand inhibitors) and antiangiog...

Alternative Titles

Full title

Medication-related osteonecrosis of the jaw: Clinical and practical guidelines

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4820581

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4820581

Other Identifiers

ISSN

2231-0762

E-ISSN

2250-1002

DOI

10.4103/2231-0762.178742

How to access this item